Virpax Pharmaceuticals Announces Appointment of Barbara A. Ruskin, Ph.D, J.D. to the Board of Directors

Author's Avatar
Mar 28, 2023

%3Cb%3EVirpax%3Csup%3E%26reg%3B%3C%2Fsup%3E+Pharmaceuticals%2C+Inc.%3C%2Fb%3E (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, announced today that the Company has appointed Barbara+A.+Ruskin%2C+Ph.D%2C+J.D. to its Board of Directors, increasing the size of the Board to nine members.